SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-18-000004
Filing Date
2018-01-04
Accepted
2018-01-04 09:03:25
Documents
3
Period of Report
2018-01-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 2017 REVENUE PRESS RELEASE a2017revenue8-k.htm 8-K 26753
2 EXHIBIT 99.1 a2017revenueex991.htm EX-99.1 17543
3 paciralogoa08.jpg GRAPHIC 63011
  Complete submission text file 0001396814-18-000004.txt   132466
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 18508546
SIC: 2834 Pharmaceutical Preparations